These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8823808)

  • 41. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
    Roberts JJ; Walker JB
    Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
    Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
    Kwon YE; Park JY; Kim WK
    Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
    Rostom SA; Ashour HM; Abd El Razik HA
    Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A short review on creatine-creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy.
    Patra S; Ghosh A; Roy SS; Bera S; Das M; Talukdar D; Ray S; Wallimann T; Ray M
    Amino Acids; 2012 Jun; 42(6):2319-30. PubMed ID: 21769499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
    Kornacker M; Schlattner U; Wallimann T; Verneris MR; Negrin RS; Kornacker B; Staratschek-Jox A; Diehl V; Wolf J
    Int J Cancer; 2001 Nov; 94(4):513-9. PubMed ID: 11745437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.
    Schiffenbauer YS; Meir G; Cohn M; Neeman M
    Am J Physiol; 1996 Jan; 270(1 Pt 1):C160-9. PubMed ID: 8772441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of rate of tumor growth by creatine and cyclocreatine.
    Miller EE; Evans AE; Cohn M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3304-8. PubMed ID: 8475072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of 15 antineoplastic drugs on colon carcinoma growing in vitro: a screening assay for cytotoxicity (author's transl)].
    Gouget N; Jeannin JF; Olsson O; Martin F
    Bull Cancer; 1980; 67(2):155-60. PubMed ID: 7448437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Creatine ethyl ester: a new substrate for creatine kinase.
    Ravera S; Adriano E; Balestrino M; Panfoli I
    Mol Biol (Mosk); 2012; 46(1):162-5. PubMed ID: 22642114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formation of a supplemental long time-constant reservoir of high energy phosphate by brain in vivo and in vitro and its reversible depletion by potassium depolarization.
    Woznicki DT; Walker JB
    J Neurochem; 1979 Jul; 33(1):75-80. PubMed ID: 458473
    [No Abstract]   [Full Text] [Related]  

  • 55. Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro.
    Robertson CN; Roberson KM; Pinero A; Jaynes JM; Paulson DF
    World J Urol; 1998; 16(6):405-9. PubMed ID: 9870289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
    Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
    J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energistic considerations.
    Annesley TM; Walker JB
    Biochem Biophys Res Commun; 1977 Jan; 74(1):185-90. PubMed ID: 836276
    [No Abstract]   [Full Text] [Related]  

  • 58. [Human amniotic fluid research. In vitro antineoplastic activity].
    Gheri Bryk S; Marchesi L; Di Preta F
    Arch Ital Anat Embriol; 1981; 86(4):363-84. PubMed ID: 6890333
    [No Abstract]   [Full Text] [Related]  

  • 59. Formation and utilization of novel high energy phosphate reservoirs in Ehrlich ascites tumor cells. Cyclocreatine-3-P and creatine-P.
    Annesley TM; Walker JB
    J Biol Chem; 1978 Nov; 253(22):8120-5. PubMed ID: 568626
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiproliferative activity of synthetic tetrapeptides, analogs of AS-I phytotoxin, towards cancer cell lines.
    Liakopoulou-Kyriakides M; Stavropoulos G; Geromichalos G; Papazisis KT; Kortsaris AH; Kyriakidis DA
    Anticancer Drugs; 1998 Feb; 9(2):175-9. PubMed ID: 9510504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.